Literature DB >> 15980208

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Emine Kilic1, Nicole C Naus, Walter van Gils, Caroline C Klaver, Marjan E van Til, Michael M Verbiest, Theo Stijnen, Cornelia M Mooy, Dion Paridaens, H Berna Beverloo, Gregorius P Luyten, Annelies de Klein.   

Abstract

PURPOSE: Uveal melanoma is a highly malignant disease with a mortality rate of 50% at 10 to 15 years. Previous studies have shown that chromosomal changes are associated with decreased survival of the patient. However, in these studies the small number of tumors analyzed did not allow robust statistical analysis. In the present study, the independent numerical changes in chromosomes 1, 3, 6, and 8 on disease-free survival (DFS) was assessed in a large series of patients with uveal melanoma.
METHODS: One hundred twenty tumors from patients with uveal melanoma were analyzed for numerical changes in chromosomes 1, 3, 6, and 8, with cytogenetic analysis, fluorescent in situ hybridization, and/or comparative genomic hybridization. Data were correlated with disease outcome in univariate and multivariate analyses, by Kaplan-Meier and Cox regression analyses.
RESULTS: At a mean follow-up time of 45 months, 42 patients had died or had metastatic disease. In the univariate analysis, loss of chromosome 3, gain of 8q, largest tumor diameter, or the presence of epithelioid cells was associated with a decreased DFS. In the multivariate analysis, the effect of monosomy 3 on survival was largely modified by changes in 1p36. Regarding all chromosomal changes, only the concurrent loss of the short arm of chromosome 1 and all of chromosome 3 was an independent prognostic parameter for disease-free survival (P < 0.001).
CONCLUSIONS: In uveal melanoma, concurrent loss of the short arm of chromosome 1 and all of chromosome 3 is an independent predictor of decreased DFS.

Entities:  

Mesh:

Year:  2005        PMID: 15980208     DOI: 10.1167/iovs.04-1460

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA.

Authors:  Duncan E Berry; Amy C Schefler; Michael I Seider; Miguel Materin; Sandra Stinnett; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2018-11-08       Impact factor: 4.256

Review 2.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 3.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

4.  FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas.

Authors:  Laura Bonaldi; Edoardo Midena; Barbara Filippi; Elisabetta Tebaldi; Raffaella Marcato; Raffaele Parrozzani; Alberto Amadori
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

5.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06

6.  HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

Authors:  Guangcun Cheng; Jie He; Leilei Zhang; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-23

Review 7.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

Review 8.  An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes.

Authors:  James J Augsburger; Zélia M Corrêa; Nikolaos Trichopoulos
Journal:  Trans Am Ophthalmol Soc       Date:  2007

9.  Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.

Authors:  J Bauer; E Kilic; J Vaarwater; B C Bastian; C Garbe; A de Klein
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

10.  Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.

Authors:  Abhirami Radhakrishnan; Nirmala Badhrinarayanan; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2009-10-22       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.